GPI-5693

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGPI-5693
Drug Alias NameGPI-5693
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsNeuralgiaDiabetic NeuropathiesProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Co Ltd
Active IndicationsN/A
Inactive IndicationsNeuralgiaDiabetic NeuropathiesProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A